• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    AusperBio`s AHB-137 Gets Breakthrough Status For Chronic Hepatitis B

    PR NEWSWIRE

    AusperBio`s AHB-137 Gets Breakthrough Status For Chronic Hepatitis B

    PR NEWSWIRE

    AusperBio Announces Major Progress in AHB-137 Clinical Development

    PR NEWSWIRE

    AusperBio Announces FDA Clearance of IND Application of AHB-137

    PR NEWSWIRE

    AusperBio to Present Two Posters on AHB-137

    PR NEWSWIRE

    AusperBio completes first patient dosing in phase 1 trial of AHB-137

    PHARMABIZ

    AusperBio Announces First-in-Human Dosing of AHB-137

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.